Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

22.40
Delayed Data
As of Apr 21
 -0.15 / -0.67%
Today’s Change
17.92
Today|||52-Week Range
36.83
-35.63%
Year-to-Date
AMAG Files for FDA Approval of Subcutaneous Form of Makena
Apr 18 / Zacks.com - Paid Partner Content
TherapeuticsMD Falls on Likely Delay in TX-004HR Approval
Apr 12 / Zacks.com - Paid Partner Content